BridgeMD
Tests treatment safety and results for Radiculopathy, Cervical
Official title Cervical Arthroplasty Cost Effectiveness Study (CACES)
ClinicalTrials.gov ID: NCT04623593
What this study is testing
- What it's testing
- To date, no consensus exists on which anterior surgical technique is more cost-effective to treat cervical degenerative disc disease (CDDD). The most commonly used surgical treatment for patients with single- or multilevel symptomatic CDDD is anterior cervical discectomy with fusion (ACDF).
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Indication for anterior cervical decompression surgery.
- Single- or multilevel CDDD between C3 and C7.
- Symptoms of myelopathy, radiculopathy, or myeloradiculopathy.
- In case of pure radiculopathy: refractory to at least 6 weeks of conservative therapy.
- In case of myelopathy: symptomatic myelopathy.
You likely can't join if
- Indication for (additional) posterior surgical approach.
- Indication for additional stabilization of the pathological segment by a plate.
- Previous ventral surgery of the cervical spine.
- Traumatic origin of the compression.
- Previous radiotherapy of the cervical spine.
- Metabolic bone disease.
See the full eligibility criteria
- Indication for anterior cervical decompression surgery.
- Single- or multilevel CDDD between C3 and C7.
- Symptoms of myelopathy, radiculopathy, or myeloradiculopathy.
- In case of pure radiculopathy: refractory to at least 6 weeks of conservative therapy.
- In case of myelopathy: symptomatic myelopathy.
- Patients ≥ 18 years of age.
- Indication for (additional) posterior surgical approach.
- Indication for additional stabilization of the pathological segment by a plate.
- Previous ventral surgery of the cervical spine.
- Traumatic origin of the compression.
- Previous radiotherapy of the cervical spine.
- Metabolic bone disease.
- Inflammatory spinal disease: e.g., Bechterew's disease, Forestier's disease.
- Infection of the cervical spine.
The study team makes the final eligibility decision.
Where it's taking place
- Maastricht, Limburg, Netherlands
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Maastricht, Limburg, Netherlands. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.